Pfizer raises expectations after huge rollout of Covid-19 vaccine

Revenue was 14.58 billion dollars (£10.51 billion), also easily exceeding forecasts of 13.49 billion dollars from industry analysts

World: Dan Kitwood/PA

Pfizer is raising its revenue expectations for the year with a huge rollout of its Covid-19 vaccine as well as strong performances from other parts of its business.

The company reported first-quarter earnings of 4.88 billion dollars (£3.52 billion), or 86 cents per share.